Cost-Effectiveness of CT Screening in the National Lung Screening Trial

The authors examined cost-effectiveness in the National Lung Screening Trial (NLST), examining incremental cost-effectiveness ratio (ICER) and quality-adjusted life years (QALYs) associated with low dose CT screening.  The ICER was $52,000 per life-year gained and the $81,000 per QALY gained.  These values were very sensitive to variations in the screening algorithms.